For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day. Now, researchers from the University of Waterloo have developed a topical solution containing nanoparticles that will combat dry eye syndrome with only one application a week.
The eye drops progressively deliver the right amount of drug-infused nanoparticles to the surface of the eyeball over a period of five days before the body absorbs them. One weekly dose replaces 15 or more to treat the pain and irritation of dry eyes.
The nanoparticles, about 1/1000th the width of a human hair, stick harmlessly to the eye’s surface and use only five per cent of the drug normally required.
“You can’t tell the difference between these nanoparticle eye drops and water,” said Shengyan (Sandy) Liu, a PhD candidate at Waterloo’s Faculty of Engineering, who led the team of researchers from the Department of Chemical Engineering and the Centre for Contact Lens Research. “There’s no irritation to the eye.”
Dry eye syndrome is a more common ailment for people over the age of 50 and may eventually lead to eye damage. More than six per cent of people in the U.S. have it. Currently, patients must frequently apply the medicine three times a day because of the eye’s ability to self-cleanse—a process that washes away 95 per cent of the drug.
“I knew that if we focused on infusing biocompatible nanoparticles with Cyclosporine A, the drug in the eye drops, and make them stick to the eyeball without irritation for longer periods of time, it would also save patients time and reduce the possibility of toxic exposure due to excessive use of eye drops,” said Liu.
The research team is now focusing on preparing the nanoparticle eye drops for clinical trials with the hope that this nanoparticle therapy could reach the shelves of drugstores within five years.
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day. Now, researchers from the University of Waterloo have developed a topical solution containing nanoparticles that will combat dry eye syndrome with only one application a week.
The eye drops progressively deliver the right amount of drug-infused nanoparticles to the surface of the eyeball over a period of five days before the body absorbs them. One weekly dose replaces 15 or more to treat the pain and irritation of dry eyes.
The Latest on: Drug-infused nanoparticle
'Russian doll' therapy for cancer that killed Tessa Jowell - The Times
June 15, 2019 - 'Russian doll' therapy for cancer that killed Tessa Jowell The TimesScientists are developing the world's first “Russian doll” therapy to treat the most lethal type of brain tumour, in a research effort inspired by the late Tessa Jowell.
Prototype diagnostic patch picks up on a chemical below the skin - Chemical & Engineering News
May 30, 2019 - Prototype diagnostic patch picks up on a chemical below the skin Chemical & Engineering NewsMarrying microneedles and plasmonic paper allowed researchers to sample interstitial fluid (ISF) from rat skin (right) and detect a dye using surface-enhanced ...June 17, 2019 - Oasmia Pharmaceutical AB: Swedish Company Targeting Ovarian Cancer, But Doesn't Impress Seeking AlphaOASM's drug is already approved in multiple geographies. However, we agree with a dissenting CHMP opinion that doesn't find the drug well-differentiated from ...
Scientists say nanotechnology in cannabis needs cautious approach, more research - Vancouver Sun
June 10, 2019 - Scientists say nanotechnology in cannabis needs cautious approach, more research Vancouver SunTrait Biosciences uses glycosylation to turn fat-based cannabinoids into water-soluble ones. It says tech used by other firms is risky.
Bioengineered lungs: How long from pigs to people? - TMC News - Texas Medical Center News
June 3, 2019 - Bioengineered lungs: How long from pigs to people? - TMC News Texas Medical Center NewsIn 2001, pediatric anesthesiologist Joaquin Cortiella, M.D., arrived at The University of Texas Medical Branch at Galveston for a job interview. Over lunch at the ...10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? - The Philadelphia Inquirer
June 10, 2019 - 10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? The Philadelphia InquirerVerve Therapeutics is considering a half-dozen candidate genes that could be edited with the CRISPR technique in order to sharply reduce a patient's levels of ...
June 9, 2019 - The Week In Cannabis: Gillibrand's Legalization Plan, Analyst Ratings, South Africa's CBD Store, And Some Legal News MarketWatchIn another big week for cannabis, a committee of the Delaware House of Representatives passed a bill to legalize recreational marijuana; Democratic...
- April 26, 2019 - Synthetic and living micropropellers for convection-enhanced nanoparticle transport Science AdvancesNanoparticles (NPs) have emerged as an advantageous drug delivery platform for the treatment of various ailments including cancer and cardiovascular and ...
- June 11, 2019 - Global Ocular Drug Delivery Technology Market Forecast by Development, Trend and Forecast (2019-2024) with CAGR +6% with Key Players OCULAR THERAPEUTIX,Alimera Sciences,Allergan,EyeGate Pharma,Valeant Pharmaceuticals International. Market Research ReportThe Ocular Drug Delivery Technology Market 2019 Information Report is selected in a professional and concise manner to provide a better understanding to our ...
December 6, 2018 - Global Nanoparticle Nanomedicine Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2024 | MedgadgetGlobal Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2024” Report Highlights: Nanoparticle Drug Market: US$ 200 Billion.
via Google News
The Latest on: Drug-infused nanoparticle
- Drug-infused hydrogel coatings add firepower to nanoshell cancer treatment on July 15, 2018 at 5:00 pm
Building on previous work, researchers at Duke University have developed a new technology that wraps nanoshells in a thin film of drug-infused hydrogel, adding additional firepower to the already ... […]
- Scientists Develop Experimental “Nano-Chemo” Particle to Treat Bladder Cancer on October 16, 2017 at 6:13 am
The team of investigators from the Brady Urological Institute and the Center for Nanomedicine at Johns Hopkins, engineered the nanoparticles from biologically compatible materials, such as ... […]
- Drug-delivery method holds promise for controlling crop parasites on May 31, 2017 at 7:16 am
In testing with the nematode Caenorhabdiis elegans, in a liquid culture, the scientists confirmed that nematodes were paralyzed and killed by treatment with the drug-infused virus-nanoparticle - this ... […]
- Nanoparticle drug-delivery method holds promise for controlling crop parasites on May 30, 2017 at 5:00 pm
In testing with the nematode Caenorhabdiis elegans, in a liquid culture, the scientists confirmed that nematodes were paralyzed and killed by treatment with the drug-infused virus-nanoparticle – this ... […]
- Focus on Health Care at Materials Day on September 30, 2015 at 5:00 pm
Grinstaff’s presentation focused on his lab’s work in using drug-infused nanoparticles to treat mesothelioma, a highly fatal cancer associated with asbestos exposure. Mesothelioma progresses locally, ... […]
- Nanoparticle drops to combat dry eye syndrome on October 8, 2014 at 5:00 pm
The eye drops progressively deliver the right amount of drug-infused nanoparticles to the surface of the eyeball over a period of five days before the body absorbs them. One weekly dose replaces 15 or ... […]
- Drug-infused nanoparticle is right for sore eyes on October 7, 2014 at 5:00 pm
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day. Now, researchers from the University of ... […]
- Drug-infused nanoparticle is right for sore eyes on October 7, 2014 at 5:00 pm
For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day. Now, researchers have developed a topical ... […]
- Stealthy Nanoparticles Attack Cancer Cells on November 3, 2009 at 4:00 pm
The vats are designed to violently shake a mix of chemicals into precise nanostructures, and Troiano’s task, as head of process development at start-up BIND Biosciences, is to make kilograms of the ... […]
- Drug-Infused Nanoparticles Stop Cancer From Spreading on July 13, 2008 at 5:00 pm
In an experiment described today in the Proceedings of the National Academy of Sciences, researchers led by University of California, San Diego pathologist David Cheresh designed nanoparticles that ... […]
via Bing News
